IP6K1 and cancer: Moreover, IP6K1 knockout (KO) in mice protects against 4-nitroquinoline-1-oxide (4-NQO)–induced carcinogenesis and diminishes the progression of invasive carcinoma (Jadav et al. 2016), suggesting IP6K1’s pro-tumorigenic action in cancer cells.